Načítá se...
FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
<p>Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Da...
Uloženo v:
Hlavní autoři: | , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Edice: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Témata: | |
On-line přístup: | http://www.rpcardio.ru/jour/article/view/284 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|